SEC
SlamSEC
SearchBrowseEarnings

Moderna, Inc.

Nasdaq:MRNA
Biological Products, (No Diagnostic Substances)·CAMBRIDGE, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

2 shown
FiledDescription
3/5/26
1.01
Material Agreement
→
11/24/25
1.012.03
Material Agreement · New Debt Obligation
→

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

CEO
Bancel Stephane
CFO
Mock James M